HBLFX | MROSX | HBLFX / MROSX | |
Total Expense Ratio | 0.56 | 0.69 | 81% |
Annual Report Gross Expense Ratio | 0.56 | 0.69 | 81% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 4.096 | 3.657 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.8B | 182M | 6,484% |
Annual Yield % from dividends | 3.68 | 3.26 | 113% |
Returns for 1 year | 4.78 | 5.99 | 80% |
Returns for 3 years | 16.94 | 16.76 | 101% |
Returns for 5 years | 17.86 | 12.81 | 139% |
Returns for 10 years | N/A | 19.00 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AZNAX | 11.06 | -0.07 | -0.63% |
Virtus Income & Growth A | |||
FBTCX | 20.46 | -0.13 | -0.63% |
Fidelity Advisor Biotechnology C | |||
MSCUX | 11.89 | -0.15 | -1.25% |
Morgan Stanley American Resilience A | |||
NGRRX | 33.08 | -0.43 | -1.28% |
Nuveen International Value I | |||
MNHCX | 25.58 | -0.40 | -1.54% |
Manning & Napier Pro-Blend Max Term L |